Omeros Corporation

(NASDAQ:OMER)

Latest On Omeros Corporation (OMER):

Date/Time Type Description Signal Details
2023-05-17 06:30 ESTNewsOmeros: Q1 Earning Overview, Best Contrarian Biotech Play Of 2023N/A
2023-05-10 05:46 ESTNewsOmeros Corporation (OMER) Q1 2023 Earnings Call TranscriptN/A
2023-05-09 16:40 ESTNewsOmeros GAAP EPS of -$0.63 misses by $0.09N/A
2023-05-09 02:50 ESTNewsOmeros Q1 2023 Earnings PreviewN/A
2023-04-25 20:18 ESTNewsOmeros reports positive data for rare blood disorder candidateN/A
2023-04-11 01:47 ESTNewsOmeros awarded $6.69M grant from NIH for cocaine use disorder treatmentN/A
2023-03-27 18:48 ESTNewsOmeros Q4: Strong Financials And IgAN Pipeline Readout In Q3 23N/A
2023-03-15 00:03 ESTNewsOmeros stock climbs amid Q4 Omidria royalty revenue; eyes FDA refiling for narsoplimabN/A
2023-03-14 08:12 ESTNewsOmeros Corporation (OMER) Q4 2022 Earnings Call TranscriptN/A
2023-03-13 17:09 ESTNewsOmeros GAAP EPS of -$0.73 misses by $0.16N/A
2023-03-13 02:04 ESTNewsOmeros Q4 2022 Earnings PreviewN/A
2023-02-08 10:56 ESTNewsOmeros: $200M Added To The Company's Balance Sheet, Upgrading To Strong BuyN/A
2023-02-06 20:54 ESTNewsOmeros up 35% in premarket trading following $200M milestone paymentN/A
2023-02-04 12:40 ESTNewsOmeros: Worst Has Been Priced In, We Like Its IgAN Pipeline, Initiating With A BuyN/A
2022-12-27 10:19 ESTNewsOmeros' Deafening SilenceN/A
2022-11-10 03:58 ESTNewsOmeros GAAP EPS of -$0.28 beats by $0.28N/A
2022-11-10 03:58 ESTNewsOmeros Corporation (OMER) Q3 2022 Earnings Call TranscriptN/A
2022-11-09 10:03 ESTNewsOmeros Q3 2022 Earnings PreviewN/A
2022-11-08 16:56 ESTNewsOmeros appeal of FDA Complete Response Letter on narsoplimab denied; shares down 7%N/A
2022-11-08 16:55 ESTNewsOmeros downgraded at Bank of America after FDA snub for narsoplimab appealN/A
2022-11-01 13:32 ESTNewsOmeros: FDA Appeal On Narsoplimab And Several 2023 Catalysts On DeckN/A
2022-10-05 09:58 ESTNewsOmeros: Taking It To The MaxN/A
2022-09-15 20:07 ESTNewsOmeros falls 11% after reporting clinical data for COVID-19 therapyN/A
2022-08-20 05:51 ESTNewsOmeros: Off To Never-Never LandN/A
2022-08-17 22:29 ESTNewsOmeros receives response from FDA on formal dispute resolution requestN/A
2022-08-16 11:56 ESTNewsOmeros: Managing An Investment After A Winning TradeN/A
2022-08-10 03:57 ESTNewsOmeros GAAP EPS of -$0.49N/A
2022-08-10 03:57 ESTNewsOmeros Corporation (OMER) CEO Gregory Demopulos on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-09 06:07 ESTNewsOmeros Q2 2022 Earnings PreviewN/A
2022-07-29 02:53 ESTNewsOmeros granted FDA’s orphan drug designation for PNH candidateN/A
2022-07-05 17:38 ESTNewsAfter gaining 69% in single trading day, Omeros stock gives back some gainsN/A
2022-07-04 07:08 ESTNewsOmeros: Follow The Bouncing BallN/A
2022-06-08 22:55 ESTNewsOmeros slips to 52-week low as stock down 9%N/A
2022-06-07 00:28 ESTNewsClover Health, Aurinia Pharma among the top 10 health care additions to Russell 3000 Index, Asensus Surgical, Clovis Oncology among top deletionsN/A
2022-06-02 12:43 ESTNewsOmeros: On Death's DoorN/A
2022-05-12 03:01 ESTNewsOmeros stock rises 7% after beating Q1 earnings estimateN/A
2022-05-11 07:21 ESTNewsOmeros GAAP EPS of -$0.53 beats by $0.08N/A
2022-05-11 07:21 ESTNewsOmeros Corporation (OMER) CEO Greg Demopulos on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-10 11:19 ESTNewsOmeros Q1 2022 Earnings PreviewN/A
2022-05-03 00:21 ESTNewsOmeros: The Weight Of The Wait, A ConundrumN/A
2022-03-02 04:45 ESTNewsOmeros Non-GAAP EPS of -$0.37 misses by $0.31N/A
2022-03-02 04:44 ESTNewsOmeros Corporation's (OMER) CEO Greg Demopulos On Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-01 10:49 ESTNewsOmeros Q4 2021 Earnings PreviewN/A
2022-02-21 13:04 ESTNewsOmeros: Despite Its Promise, The CRL Is A Huge ObstacleN/A
2022-01-20 07:52 ESTNewsOmeros responds to Complete Response Letter on narsoplimab for kidney damageN/A
2022-01-19 00:54 ESTNewsOmeros could trade as a pure-play biotech after divesting Omidria - CantorN/A
2021-12-06 20:03 ESTNewsOmeros: A New Year BeckonsN/A
2021-12-02 22:53 ESTNewsOmeros to sell OMIDRIA franchise to Rayner Surgical for more than $1BN/A
2021-11-10 13:19 ESTNewsOmeros EPS beats by $0.01, beats on revenueN/A
2021-11-10 13:19 ESTNewsOmeros Corporation (OMER) CEO Greg Demopulos on Q3 2021 Results - Earnings Call TranscriptN/A

About Omeros Corporation (OMER):

Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, disorders of the central nervous system (CNS), and immune-related diseases. It provides OMIDRIA for use in cataract surgery or intraocular lens replacement in the United States. The company's clinical programs include Narsoplimab (OMS721/MASP-2) for hematopoietic stem-cell transplant-associated thrombotic microangiopathy (HSCT-TMA); that is in Phase III clinical trial for immunoglobulin A nephropathy (IgAN), atypical hemolytic uremic syndrome (aHUS), and COVID-19; and Phase II clinical trial to treat lupus nephritis and other renal diseases. Its clinical programs also consist of PPAR? (OMS405) to treat opioid and nicotine addiction; PDE7 (OMS527) for treating addiction and compulsive disorders, and movement disorders; and MASP-3 (OMS906) for paroxysmal nocturnal hemoglobinuria (PNH) and other alternative pathway disorders. The company's preclinical programs comprise MASP-2-small-molecule inhibitors used for the treatment of aHUS, IgAN, HSCT-TMA, and age-related macular degeneration; longer-acting second generation antibody targeting MASP-2; and MASP-3-small-molecule inhibitors to treat PNH and other alternative pathway disorders. Its preclinical programs include G protein-coupled receptor (GPCR) platform, including GPR174, GPR151, GPR161, and other Class A orphan GPCRs for treating immunologic, immuno-oncologic, metabolic, CNS, cardiovascular, musculoskeletal, and other disorders. The company was incorporated in 1994 and is headquartered in Seattle, Washington.

OMER Quotes by TradingView

See Advanced Chart

General

  • Name Omeros Corporation
  • Symbol OMER
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 277
  • Last Split Factor1:1
  • Last Split Date2009-10-02
  • Fiscal Year EndDecember
  • IPO Date2009-10-08
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.omeros.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 15.4
  • Enterprise Value Revenue 18.49
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.77
  • Next Year EPS Estimate -$1.12
  • Next Quarter EPS Estimate -$0.54
  • Profit Margin -187%
  • Operating Margin -150%
  • Return on Assets -43%
  • Revenue 73.81 million
  • Earnings Per Share -$2.08
  • Revenue Per Share $1.29
  • Gross Profit 6.17 million
  • Quarterly Earnings Growth -68.2%
View More

Highlights

  • Market Capitalization 1.23 billion
  • EBITDA -81135000
  • PE Ratio -1.97
  • PEG Ratio -0.17
  • Analyst Target Price $27.33
  • Book Value Per Share -$2.65
View More

Share Statistics

  • Shares Outstanding 61.93 million
  • Shares Float 55.03 million
  • % Held by Insiders 441%
  • % Held by Institutions 57.36%
  • Shares Short 12.55 million
  • Shares Short Prior Month 12.76 million
  • Short Ratio 16
  • Short % of Float 21%
  • Short % of Shares Outstanding 20%
View More

Technicals

  • Beta 1.42
  • 52 Week High $23.14
  • 52 Week Low $9.25
  • 50 Day Moving Average 20.56
  • 200 Day Moving Average 14.72
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Omeros Corporation (OMER) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Omeros Corporation (OMER) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-01$N/A-$0.60-$0.6710.39%
2020-09-302020-11-09$N/A-$0.34-$0.4930.04%
2020-06-302020-08-10$N/A-$0.61-$0.59-4.1%
2020-03-312020-05-11$23.54 million-$0.53-$0.34-55.88%
2019-12-312020-03-02$33.42 million-$0.58-$0.40-45%
2019-09-302019-11-12$29.86 million-$0.33-$0.4119.02%
2019-06-302019-08-08$26.75 million-$0.29-$0.4434.09%
2019-03-312019-05-09$21.78 million-$0.50-$0.47-5.82%
2018-12-312019-03-01$22.02 million-$0.48-$0.7333.89%
2018-09-302018-11-08$4.61 million-$0.81-$0.71-14.62%
2018-06-302018-08-09$1.66 million-$0.70-$0.62-12.45%
2018-03-312018-05-10$1.59 million-$0.62-$0.59-5.68%
2017-12-312018-03-01$13.76 million-$0.34-$0.18-91.55%
2017-09-302017-11-09$21.66 million-$0.16-$0.3453.22%
2017-06-302017-08-08$17.15 million-$0.33-$0.3710.81%
2017-03-312017-05-10$12.26 million-$0.34-$0.364.23%
2016-12-312017-03-16$12.91 million-$0.33-$0.5641.96%
2016-09-302016-11-09$11.29 million-$0.34-$0.364.9%
2016-06-302016-08-09$10 million-$0.32-$0.4934.16%
2016-03-312016-05-10$7.42 million-$0.54-$0.43-25.58%
2015-12-312016-03-07$6.68 million-$0.49-$0.5917.87%
2015-09-302015-11-09$3.26 million-$0.53-$0.47-12.77%
2015-06-302015-08-10$3.19 million-$0.44-$0.5621.43%
2015-03-312015-05-11$388000-$0.51-$0.6319.05%
2014-12-312015-03-16$180000-$0.61-$0.621.61%
2014-09-302014-11-10$214000-$0.54-$0.598.47%
2014-06-302014-08-11$45000-$0.53-$0.565.36%
2014-03-312014-05-12$100000-$0.54-$0.45-20%
2013-12-312014-03-13$169000-$0.47-$0.38-23.68%
2013-09-302013-11-07$196000-$0.46-$0.44-4.55%
2013-06-302013-08-09$140000-$0.48-$0.38-26.32%
2013-03-312013-05-10$1.1 million-$0.40-$0.39-2.56%
2012-12-312013-03-18$1.58 million-$0.45-$0.34-32.35%
2012-09-302012-11-09$1.42 million-$0.36-$0.34-5.88%
2012-06-302012-08-07$1.53 million-$0.38-$0.36-5.56%
2012-03-312012-05-10$1.5 million-$0.35-$0.362.78%
2011-12-312012-03-15$1.14 million-$0.46-$0.35-31.43%
2011-09-302011-11-08$987000-$0.29-$0.3823.68%
2011-06-302011-08-09$1.16 million-$0.24-$0.3836.84%
2011-03-312011-05-10$1.24 million-$0.30-$0.3923.08%
2010-12-312011-03-15$976000-$0.32-$0.4934.69%
2010-09-302010-11-04$254000-$0.35-$0.3910.26%
2010-06-302010-08-10$497000-$0.36-$0.33-9.09%
2010-03-312010-05-12$378000-$0.31-$0.30-3.33%
2009-12-312010-03-31$434000-$0.28-$0.27-3.7%
2009-09-302009-11-19$442000-$0.33-$0.3710.81%

Omeros Corporation (OMER) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Omeros Corporation (OMER) Chart:

Omeros Corporation (OMER) News:

Below you will find a list of latest news for Omeros Corporation (OMER) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Omeros Corporation (OMER) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-09-1913.3CALL0 1804.37TRUE00
2025-09-1920CALL0 0483.5TRUE00
2025-09-1931.55CALL4 141114.96TRUE0.110.08
2025-09-1940.7CALL16 28885.66TRUE0.70
2025-09-1950.6CALL162 8005156.9FALSE0.060.11
2025-09-1960.4CALL21 3703167.83FALSE0.21
2025-09-1970.25CALL24 109169.29FALSE0.250
2025-09-1980.2CALL15 6183.01FALSE0.050.33
2025-09-1910PUT0 0299.42FALSE00
2025-09-1920PUT0 0168.32FALSE00
2025-09-1930.15PUT2 153154.57FALSE0.150
2025-09-1940.58PUT0 262141.27FALSE00
2025-09-1951.25PUT0 16165.91TRUE00
2025-09-1962.14PUT0 10183.07TRUE00
2025-09-1973.3PUT0 5193.11TRUE00
2025-09-1983.95PUT0 20183.12TRUE00
2025-10-1710CALL0 0488.42TRUE00
2025-10-1720CALL0 0211.21TRUE00
2025-10-1731.7CALL22 52123.91TRUE0.150.1
2025-10-1741.02CALL0 10972.21TRUE00
2025-10-1750.71CALL57 169143.01FALSE-0.04-0.05
2025-10-1760.5CALL72 2133.98FALSE-0.05-0.09
2025-10-1770CALL0 0137.28FALSE00
2025-10-1780CALL0 0153.43FALSE00
2025-10-1710PUT0 0447.6FALSE00
2025-10-1720PUT0 0189.18FALSE00
2025-10-1730PUT0 0142.2FALSE00
2025-10-1740.75PUT6 10149.6FALSE-0.05-0.06
2025-10-1750PUT0 066.06TRUE00
2025-10-1760PUT0 0147.12TRUE00
2025-10-1770PUT0 0152.22TRUE00
2025-10-1780PUT0 0152.83TRUE00
2025-11-2112.8CALL0 20383.59TRUE00
2025-11-2122.5CALL0 5157TRUE00
2025-11-2131.65CALL0 157132.97TRUE00
2025-11-2141.5CALL2 2042147.98TRUE0.250.2
2025-11-2151.1CALL3 2413142.95FALSE0.050.05
2025-11-2160.9CALL80 475149.95FALSE0.90
2025-11-2170.4CALL0 788155FALSE00
2025-11-2180.65CALL1 418160.72FALSE0.650
2025-11-2190.55CALL2 940162.84FALSE0.550
2025-11-21100.15CALL0 379161.99FALSE00
2025-11-21110.1CALL0 262165.37FALSE00
2025-11-21120CALL0 3151.47FALSE00
2025-11-21130.3CALL0 2163.22FALSE00
2025-11-21140CALL0 1182FALSE00
2025-11-21150.32CALL0 231167.69FALSE00
2025-11-21160CALL0 0190.51FALSE00
2025-11-21170.2CALL0 67163.14FALSE00
2025-11-2110PUT0 0365.83FALSE00
2025-11-2120.17PUT0 22193FALSE00
2025-11-2130.6PUT0 865156.35FALSE00
2025-11-2140.83PUT0 6327150.55FALSE00
2025-11-2151.65PUT1 107151.88TRUE1.650
2025-11-2162.43PUT0 287156.66TRUE00
2025-11-2170PUT0 10154.05TRUE00
2025-11-2184.95PUT0 41154.5TRUE00
2025-11-2190PUT0 5163.16TRUE00
2025-11-21100PUT0 0162.9TRUE00
2025-11-21110PUT0 60166.89TRUE00
2025-11-21120PUT0 0161.48TRUE00
2025-11-21130PUT0 0170TRUE00
2025-11-21140PUT0 0177.78TRUE00
2025-11-21150PUT0 0155.17TRUE00
2025-11-21160PUT0 0172.98TRUE00
2025-11-21170PUT0 0151.84TRUE00
2025-12-1912.75CALL0 10346.56TRUE00
2025-12-1920CALL0 0207.72TRUE00
2025-12-1932CALL0 299186.38TRUE00
2025-12-1941.8CALL0 449196.37TRUE00
2025-12-1951.86CALL0 1431197.63FALSE00
2025-12-1961.55CALL12 71195.42FALSE1.550
2025-12-1971.5CALL0 239199.12FALSE00
2025-12-1981.2CALL0 150197.1FALSE00
2025-12-1990.75CALL0 165200.02FALSE00
2025-12-19101CALL50 694198.59FALSE10
2025-12-19110.85CALL0 211172.49FALSE00
2025-12-19121CALL0 444203.81FALSE00
2025-12-19150.75CALL2 802211.03FALSE0.750
2025-12-19170.75CALL0 758208.13FALSE00
2025-12-1910.25PUT0 45242.1FALSE00
2025-12-1920.72PUT0 58209.22FALSE00
2025-12-1931.1PUT0 236200.52FALSE00
2025-12-1941.6PUT1 7078203.2FALSE-0.05-0.03
2025-12-1952.45PUT0 185199.41TRUE00
2025-12-1963.2PUT0 70198.12TRUE00
2025-12-1973.94PUT5 361209.18TRUE3.940
2025-12-1980PUT0 35201.48TRUE00
2025-12-1995.8PUT0 90200.31TRUE00
2025-12-19100PUT0 0202.11TRUE00
2025-12-19110PUT0 0202.35TRUE00
2025-12-19120PUT0 2201.28TRUE00
2025-12-19150PUT0 0207.7TRUE00
2025-12-19170PUT0 2202.77TRUE00
2026-02-2013.6CALL0 12225.09TRUE00
2026-02-2022.9CALL100 230153.22TRUE2.90
2026-02-2032.6CALL0 153183.99TRUE00
2026-02-2042.5CALL200 137202.49TRUE0.150.06
2026-02-2051.9CALL0 368177.41FALSE00
2026-02-2061.94CALL0 685290.06FALSE00
2026-02-2071.7CALL0 162183.11FALSE00
2026-02-2080CALL0 0266.19FALSE00
2026-02-2010.3PUT0 663317.4FALSE00
2026-02-2020.73PUT0 21206.48FALSE00
2026-02-2031.35PUT0 391198.2FALSE00
2026-02-2042.05PUT0 400194.51FALSE00
2026-02-2052.75PUT0 97193.1TRUE00
2026-02-2063.58PUT0 6203.61TRUE00
2026-02-2074.4PUT0 20201.72TRUE00
2026-02-2080PUT0 0189.77TRUE00
2026-12-1810CALL0 0193.05TRUE00
2026-12-1822.1CALL0 6130.51TRUE00
2026-12-1832.3CALL0 1118.45TRUE00
2026-12-1842.05CALL0 6132.7TRUE00
2026-12-1852.25CALL0 122150.53FALSE00
2026-12-1871.98CALL0 250169.29FALSE00
2026-12-18101.65CALL0 185138.91FALSE00
2026-12-18121.3CALL0 161100.96FALSE00
2026-12-18151.3CALL0 88192.65FALSE00
2026-12-18171.12CALL1 75127.45FALSE1.120
2026-12-1810PUT0 00FALSE00
2026-12-1820.42PUT0 4235.75FALSE00
2026-12-1831.51PUT10 85138.44FALSE1.510
2026-12-1842.48PUT0 76191.33FALSE00
2026-12-1852.93PUT0 54116.57TRUE00
2026-12-1874.88PUT0 95116.14TRUE00
2026-12-18107.2PUT4 667148.52TRUE7.20
2026-12-18120PUT0 1134.35TRUE00
2026-12-18150PUT0 2137.75TRUE00
2026-12-18170PUT0 0137.68TRUE00
2027-01-1513.4CALL0 210TRUE00
2027-01-1523.3CALL0 50189.71TRUE00
2027-01-1532.3CALL0 5941.03TRUE00
2027-01-1542.58CALL0 208118.67TRUE00
2027-01-1552CALL0 139130.11FALSE00
2027-01-1571.9CALL0 782152.12FALSE00
2027-01-15101.8CALL0 482123.86FALSE00
2027-01-15121.7CALL0 24132.52FALSE00
2027-01-15151.5CALL0 915124.66FALSE00
2027-01-15171.24CALL0 48129.97FALSE00
2027-01-1510PUT0 00FALSE00
2027-01-1520.75PUT0 70113.09FALSE00
2027-01-1531.61PUT0 13092.03FALSE00
2027-01-1540PUT0 1166.99FALSE00
2027-01-1553.1PUT0 95130.02TRUE00
2027-01-1574.62PUT0 67130.39TRUE00
2027-01-15100PUT0 12103.29TRUE00
2027-01-15120PUT0 2141.32TRUE00
2027-01-15150PUT0 1142.25TRUE00
2027-01-15170PUT0 0132.39TRUE00

Latest OMER Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$2.015
Jun 13, 2022 7:59 PM EST100$2.015
Jun 13, 2022 7:59 PM EST388$2.015
Jun 13, 2022 7:59 PM EST112$2.015
Jun 13, 2022 7:59 PM EST42$2.015

Omeros Corporation (OMER) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837020007464/0001558370-20-007464-index.htm
2019-12-30UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1285819/000000000019016861/0000000000-19-016861-index.htm
2020-01-31UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1285819/000000000020000924/0000000000-20-000924-index.htm
2018-01-29SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000021545718003528/0000215457-18-003528-index.htm
2019-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000021545719004932/0000215457-19-004932-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000083423720005992/0000834237-20-005992-index.htm
2017-12-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924317029690/0000899243-17-029690-index.htm
2018-01-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318000628/0000899243-18-000628-index.htm
2018-01-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318000629/0000899243-18-000629-index.htm
2018-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318009872/0000899243-18-009872-index.htm
2018-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318009873/0000899243-18-009873-index.htm
2018-04-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318010008/0000899243-18-010008-index.htm
2018-05-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318013086/0000899243-18-013086-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318017006/0000899243-18-017006-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318017007/0000899243-18-017007-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318017008/0000899243-18-017008-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318017010/0000899243-18-017010-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318017011/0000899243-18-017011-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318017013/0000899243-18-017013-index.htm
2018-07-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318019862/0000899243-18-019862-index.htm
2018-07-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318020780/0000899243-18-020780-index.htm
2018-08-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm
2019-02-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319003362/0000899243-19-003362-index.htm
2019-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319003363/0000899243-19-003363-index.htm
2019-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319003364/0000899243-19-003364-index.htm
2019-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319003365/0000899243-19-003365-index.htm
2019-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319003367/0000899243-19-003367-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016488/0000899243-19-016488-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016489/0000899243-19-016489-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016490/0000899243-19-016490-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016492/0000899243-19-016492-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016495/0000899243-19-016495-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016497/0000899243-19-016497-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016501/0000899243-19-016501-index.htm
2019-06-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016504/0000899243-19-016504-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016506/0000899243-19-016506-index.htm
2019-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319025638/0000899243-19-025638-index.htm
2019-12-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319028629/0000899243-19-028629-index.htm
2019-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319029501/0000899243-19-029501-index.htm
2019-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319029502/0000899243-19-029502-index.htm
2020-02-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924320004399/0000899243-20-004399-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924320004400/0000899243-20-004400-index.htm
2017-11-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000092963817000842/0000929638-17-000842-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000092963818000300/0000929638-18-000300-index.htm
2020-05-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000092963820000579/0000929638-20-000579-index.htm
2018-02-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000104188518000012/0001041885-18-000012-index.htm
2019-01-30SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000104188519000016/0001041885-19-000016-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000104188520000011/0001041885-20-000011-index.htm
2019-12-04S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1285819/000104746919006632/0001047469-19-006632-index.htm
2019-12-04424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1285819/000104746919006643/0001047469-19-006643-index.htm
2019-12-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1285819/000104746919006722/0001047469-19-006722-index.htm
2020-08-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1285819/000104746920004475/0001047469-20-004475-index.htm
2020-08-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1285819/000104746920004476/0001047469-20-004476-index.htm
2020-08-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1285819/000104746920004572/0001047469-20-004572-index.htm
2020-08-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1285819/000104746920004574/0001047469-20-004574-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000108514620000787/0001085146-20-000787-index.htm
2019-12-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000110465919070697/0001104659-19-070697-index.htm
2020-01-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1285819/000110465920002951/0001104659-20-002951-index.htm
2020-01-13AWAmendment Withdrawal Requesthttps://www.sec.gov/Archives/edgar/data/1285819/000110465920003470/0001104659-20-003470-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000110465920021736/0001104659-20-021736-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000110465920021842/0001104659-20-021842-index.htm
2020-08-10FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1285819/000110465920092744/0001104659-20-092744-index.htm
2020-08-10305B2Filing [Trust Indenture Act]https://www.sec.gov/Archives/edgar/data/1285819/000110465920092747/0001104659-20-092747-index.htm
2020-08-12FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1285819/000110465920093476/0001104659-20-093476-index.htm
2020-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000110465920095326/0001104659-20-095326-index.htm
2019-03-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000114420419012997/0001144204-19-012997-index.htm
2019-05-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000114420419025259/0001144204-19-025259-index.htm
2017-08-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312517265505/0001193125-17-265505-index.htm
2017-10-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312517304636/0001193125-17-304636-index.htm
2017-10-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312517311379/0001193125-17-311379-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000119312518045759/0001193125-18-045759-index.htm
2018-03-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312518096839/0001193125-18-096839-index.htm
2018-04-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312518116023/0001193125-18-116023-index.htm
2018-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312518169610/0001193125-18-169610-index.htm
2018-05-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312518172720/0001193125-18-172720-index.htm
2018-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312518195704/0001193125-18-195704-index.htm
2018-10-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312518294184/0001193125-18-294184-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312518322542/0001193125-18-322542-index.htm
2018-11-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312518327708/0001193125-18-327708-index.htm
2019-01-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312519009075/0001193125-19-009075-index.htm
2019-02-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312519036058/0001193125-19-036058-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000119312519038252/0001193125-19-038252-index.htm
2019-03-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312519059222/0001193125-19-059222-index.htm
2019-03-01POSASRPost-effective Amendment to an automatic shelf registration statementhttps://www.sec.gov/Archives/edgar/data/1285819/000119312519059276/0001193125-19-059276-index.htm
2019-03-01POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1285819/000119312519059320/0001193125-19-059320-index.htm
2019-06-11S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1285819/000119312519170318/0001193125-19-170318-index.htm
2018-03-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1285819/000128581918000003/0001285819-18-000003-index.htm
2018-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000128581918000006/0001285819-18-000006-index.htm
2018-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000128581918000011/0001285819-18-000011-index.htm
2018-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000128581918000014/0001285819-18-000014-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920000610/0001415889-20-000610-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920000611/0001415889-20-000611-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920000612/0001415889-20-000612-index.htm
2020-03-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920000797/0001415889-20-000797-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920001228/0001415889-20-001228-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920001531/0001415889-20-001531-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920001532/0001415889-20-001532-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920001533/0001415889-20-001533-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920001534/0001415889-20-001534-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920001535/0001415889-20-001535-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920001536/0001415889-20-001536-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920001537/0001415889-20-001537-index.htm
2020-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920002497/0001415889-20-002497-index.htm
2019-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837019006625/0001558370-19-006625-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837019007697/0001558370-19-007697-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837019007698/0001558370-19-007698-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000155837019007702/0001558370-19-007702-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837019010800/0001558370-19-010800-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000155837019010806/0001558370-19-010806-index.htm
2020-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837020000682/0001558370-20-000682-index.htm
2020-03-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837020001887/0001558370-20-001887-index.htm
2020-03-0210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1285819/000155837020001891/0001558370-20-001891-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1285819/000155837020004646/0001558370-20-004646-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1285819/000155837020004658/0001558370-20-004658-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837020006245/0001558370-20-006245-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000155837020006254/0001558370-20-006254-index.htm
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837020007464/0001558370-20-007464-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837020010177/0001558370-20-010177-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000155837020010182/0001558370-20-010182-index.htm
2017-11-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000156459017023228/0001564590-17-023228-index.htm
2018-03-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000156459018004112/0001564590-18-004112-index.htm
2018-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1285819/000156459018009842/0001564590-18-009842-index.htm
2018-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000156459018012972/0001564590-18-012972-index.htm
2018-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000156459018021051/0001564590-18-021051-index.htm
2019-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1285819/000156459019013704/0001564590-19-013704-index.htm
2019-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000156459019017957/0001564590-19-017957-index.htm
2019-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000156459019022265/0001564590-19-022265-index.htm
2017-11-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000162828017011326/0001628280-17-011326-index.htm
2019-03-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1285819/000162828019002324/0001628280-19-002324-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000162828019006430/0001628280-19-006430-index.htm
2018-10-04CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1285819/999999999718008375/9999999997-18-008375-index.htm
2019-04-04CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1285819/999999999719002349/9999999997-19-002349-index.htm
2019-09-11CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1285819/999999999719006776/9999999997-19-006776-index.htm
2020-08-06CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1285819/999999999720004327/9999999997-20-004327-index.htm

Omeros Corporation (OMER) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Omeros Corporation (OMER). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 441%
Institutional Ownership: 5736%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-05-15MICHAEL A JACOBSENVP Finance and CAOBuy5,000.009.3746,850.0013,500.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318013086/0000899243-18-013086-index.htm
2018-01-03Marcia S. KelbonVP Patent and General CounselSell62,528.0021.451,341,225.60176,641.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318000629/0000899243-18-000629-index.htm
2018-01-03Marcia S. KelbonVP Patent and General CounselBuy3,000.006.0518,150.00179,641.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318000629/0000899243-18-000629-index.htm
2018-01-03Marcia S. KelbonVP Patent and General CounselBuy5,004.006.0530,274.20184,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318000629/0000899243-18-000629-index.htm
2018-07-12Marcia S. KelbonVP Patent and General CounselSell4,277.0021.4891,886.21184,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318019862/0000899243-18-019862-index.htm
2018-07-26Marcia S. KelbonVP Patent and General CounselSell35,000.0021.53753,686.50184,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318020780/0000899243-18-020780-index.htm
2019-12-14Peter A MD DemopulosDirectorBuy3,334.007.5625,205.04188,516.00https://www.sec.gov/Archives/edgar/data/1285819/000089924319029501/0000899243-19-029501-index.htm
2018-07-12Marcia S. KelbonVP Patent and General CounselBuy4,277.004.1017,535.70188,922.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318019862/0000899243-18-019862-index.htm
2018-07-26Marcia S. KelbonVP Patent and General CounselBuy8,000.006.0548,400.00192,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318020780/0000899243-18-020780-index.htm
2018-07-27Marcia S. KelbonVP Patent and General CounselSell5,723.0021.73124,356.78192,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318020780/0000899243-18-020780-index.htm
2018-08-30Marcia S. KelbonVP Patent and General CounselSell35,000.0024.45855,750.00192,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm
2018-08-31Marcia S. KelbonVP Patent and General CounselSell5,337.0025.93138,376.13192,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm
2018-05-14MICHAEL A JACOBSENVP Finance and CAOBuy10,980.009.37102,882.6019,480.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318013086/0000899243-18-013086-index.htm
2018-08-31Marcia S. KelbonVP Patent and General CounselSell2,192.0025.3155,469.44197,982.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm
2018-07-27Marcia S. KelbonVP Patent and General CounselBuy5,723.004.1023,464.30198,368.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318020780/0000899243-18-020780-index.htm
2017-12-28Gregory A MD DemopulosChairman, CEO & PresidentBuy102,040.002.45249,998.001,987,025.00https://www.sec.gov/Archives/edgar/data/1285819/000089924317029690/0000899243-17-029690-index.htm
2018-08-31Marcia S. KelbonVP Patent and General CounselBuy7,529.004.1030,868.90200,174.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm
2018-08-31Marcia S. KelbonVP Patent and General CounselBuy8,000.006.0548,400.00200,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm
2017-12-28Gregory A MD DemopulosChairman, CEO & PresidentBuy39,961.004.10163,840.102,026,986.00https://www.sec.gov/Archives/edgar/data/1285819/000089924317029690/0000899243-17-029690-index.htm
2019-06-07Marcia S. KelbonVP Patent and General CounselBuy10,000.006.0560,500.00210,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924319016488/0000899243-19-016488-index.htm
2018-05-15MICHAEL A JACOBSENVP Finance and CAOBuy12,812.009.37120,048.4421,312.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318013086/0000899243-18-013086-index.htm
2018-07-26Marcia S. KelbonVP Patent and General CounselBuy35,000.004.10143,500.00219,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318020780/0000899243-18-020780-index.htm
2018-08-30Marcia S. KelbonVP Patent and General CounselBuy35,000.004.10143,500.00227,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm
2018-01-03Marcia S. KelbonVP Patent and General CounselBuy62,528.009.37585,887.36239,169.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318000629/0000899243-18-000629-index.htm
2019-10-14Thomas J. CableDirectorSell5,000.0015.1275,590.0035,067.00https://www.sec.gov/Archives/edgar/data/1285819/000089924319025638/0000899243-19-025638-index.htm
2019-12-03Thomas J. CableDirectorSell10,000.0014.41144,148.0035,067.00https://www.sec.gov/Archives/edgar/data/1285819/000089924319028629/0000899243-19-028629-index.htm
2020-05-13Thomas J. CableDirectorSell5,000.0014.4071,998.5035,067.00https://www.sec.gov/Archives/edgar/data/1285819/000141588920001228/0001415889-20-001228-index.htm
2020-05-13Thomas J. CableDirectorBuy5,000.005.9229,600.0040,067.00https://www.sec.gov/Archives/edgar/data/1285819/000141588920001228/0001415889-20-001228-index.htm
2019-12-03Thomas J. CableDirectorBuy10,000.007.5675,600.0045,067.00https://www.sec.gov/Archives/edgar/data/1285819/000089924319028629/0000899243-19-028629-index.htm
2019-12-14Leroy E. MD PhD HoodDirectorBuy10,000.007.5675,600.0064,390.00https://www.sec.gov/Archives/edgar/data/1285819/000089924319029502/0000899243-19-029502-index.htm
2020-03-13Leroy E. MD PhD HoodDirectorBuy5,000.005.9229,600.0069,390.00https://www.sec.gov/Archives/edgar/data/1285819/000141588920000797/0001415889-20-000797-index.htm
2018-01-03MICHAEL A JACOBSENVP Finance and CAOSell1,020.0022.4522,899.007,500.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318000628/0000899243-18-000628-index.htm
2018-01-04MICHAEL A JACOBSENVP Finance and CAOBuy1,000.009.379,370.008,500.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318000628/0000899243-18-000628-index.htm
2018-05-14MICHAEL A JACOBSENVP Finance and CAOSell10,980.0022.45246,501.008,500.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318013086/0000899243-18-013086-index.htm
2018-05-15MICHAEL A JACOBSENVP Finance and CAOSell12,812.0024.95319,659.408,500.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318013086/0000899243-18-013086-index.htm
2018-01-03MICHAEL A JACOBSENVP Finance and CAOBuy1,020.009.379,557.408,520.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318000628/0000899243-18-000628-index.htm